Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.109 -0.271 (-4.25%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Adaptive Biotechnologies Corp at William Blair Growth Stock Conference (Virtual) Transcript

Jun 01, 2021 / 01:40PM GMT
Release Date Price: $36.63 (-3.12%)
Brian David Weinstein
William Blair & Company L.L.C., Research Division - Partner, Group Head of Life Sciences & Healthcare Analyst

Good morning. Welcome, everyone. My name is Brian Weinstein, and I'm the Group Head of Life Sciences here at William Blair, and I'm responsible for coverage of Adaptive Biotechnologies.

First off, I am required to inform you that for a complete list of research disclosures or potential conflicts that you should visit our website at williamblair.com. Logistically here, the format is a fireside chat between me and the management team that will last for about 30 minutes.

We have a set of questions prepared, which we will get through. (Operator Instructions) So with that as brief intro, let's jump in. We're really fortunate to have fellow Bears fan, Chairman, CEO and Co-Founder, Chad Robins, with us. Thanks for taking time to join us, Chad. Really appreciate it.

Chad M. Robins;Brian David
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Thanks for having me, Brian.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot